Amgen Inc. (AMGN)

Amgen beat consensus on both the top and bottom line in the second fiscal quarter of 2026, reported on August 4 based on preliminary results, with revenue of about $10.1 billion topping the about $9.4 billion estimate by 7% and adjusted EPS of $6.29 beating the $5.64 consensus by 12%. Revenue rose 10% from about $9.2 billion a year ago, while net income climbed 66% to about $2.4 billion from about $1.4 billion and adjusted EPS was up 5% from $6.02. Operating income reached about $3.5 billion as operating margin held about 35%, with gross margin near 72%. Operating cash flow was about $4.0 billion, the company paid about $1.4 billion in dividends, and consensus for the next period calls for EPS of $5.77 on revenue of $9.72 billion.